Trial Profile
A phase II trial of VBY-891 in patients with moderate-to-severe psoriasis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs VBY 891 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 07 Apr 2016 According to the information on the company website (http://www.virobayinc.com/VBY-891.php), this trial is expected to begin in the second half of 2015 and the result from the trial are expected in the first half of 2016.
- 07 Apr 2016 New trial record